Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin ; volume:10 ; number:1 ; day:16 ; month:11 ; year:2011 ; pages:1-9 ; date:12.2011
Lipids in health and disease ; 10, Heft 1 (16.11.2011), 1-9, 12.2011
- Creator
-
Farnier, Michel
Dong, Qian
Shah, Arvind
Johnson-Levonas, Amy O.
Brudi, Philippe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-511X-10-212
- URN
-
urn:nbn:de:101:1-2019062701302713868248
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Farnier, Michel
- Dong, Qian
- Shah, Arvind
- Johnson-Levonas, Amy O.
- Brudi, Philippe
- SpringerLink (Online service)
Other Objects (12)
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
Assessment of femoral bone osteoporosis in rats treated with simvastatin or fenofibrate
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
Pseudomyopia with paradoxical accommodation: a case report
Paradoxical
Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
Individualizing simvastatin dose with respect to CYP3A4 activity
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China
Referenzwerte für Apolipoproteine und HDL-2/HDL-3 [HDL-HDL] im Kindesalter
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
Delay posttraumatic paradoxical cerebrospinal fluid leak with recurrent meningitis
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
Assessment of femoral bone osteoporosis in rats treated with simvastatin or fenofibrate
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
Pseudomyopia with paradoxical accommodation: a case report
Paradoxical
Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
Individualizing simvastatin dose with respect to CYP3A4 activity
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China
Referenzwerte für Apolipoproteine und HDL-2/HDL-3 [HDL-HDL] im Kindesalter
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
Delay posttraumatic paradoxical cerebrospinal fluid leak with recurrent meningitis
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
Assessment of femoral bone osteoporosis in rats treated with simvastatin or fenofibrate
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
Pseudomyopia with paradoxical accommodation: a case report
Paradoxical
Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
Individualizing simvastatin dose with respect to CYP3A4 activity
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China
Referenzwerte für Apolipoproteine und HDL-2/HDL-3 [HDL-HDL] im Kindesalter
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study